After June 21, Medicare will limit coverage for the core drug-sensitivity genetic tests that comprise YouScript’s Polypharmacy test panel. This means that if you or a loved one are 65 or older and not taking the drugs Plavix, nortriptyline, amitriptyline or Xenazine, you will lose this Medicare benefit. Drug-sensitivity testing, also called pharmacogenetic testing, allows your doctor to know how your … Read More
Study finds opioid use common amongst disabled Medicare recipients
A recent study illuminates the prevalence of opioid painkiller use in a particularly vulnerable population: disabled Americans on Social Security disability insurance. The article, published in the September edition of the journal Medical Care, found the percentage of Social Security disability insurance (SSDI) recipients younger than 65 receiving any amount of opioid prescriptions rose from 43.9 percent in 2007 to … Read More